Correlation Between Bone Biologics and BioSig Technologies,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bone Biologics and BioSig Technologies, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bone Biologics and BioSig Technologies, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bone Biologics Corp and BioSig Technologies, Common, you can compare the effects of market volatilities on Bone Biologics and BioSig Technologies, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bone Biologics with a short position of BioSig Technologies,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bone Biologics and BioSig Technologies,.

Diversification Opportunities for Bone Biologics and BioSig Technologies,

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Bone and BioSig is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Bone Biologics Corp and BioSig Technologies, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioSig Technologies, and Bone Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bone Biologics Corp are associated (or correlated) with BioSig Technologies,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioSig Technologies, has no effect on the direction of Bone Biologics i.e., Bone Biologics and BioSig Technologies, go up and down completely randomly.

Pair Corralation between Bone Biologics and BioSig Technologies,

Given the investment horizon of 90 days Bone Biologics Corp is expected to under-perform the BioSig Technologies,. But the stock apears to be less risky and, when comparing its historical volatility, Bone Biologics Corp is 1.07 times less risky than BioSig Technologies,. The stock trades about -0.03 of its potential returns per unit of risk. The BioSig Technologies, Common is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  425.00  in BioSig Technologies, Common on September 2, 2024 and sell it today you would lose (246.00) from holding BioSig Technologies, Common or give up 57.88% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy99.8%
ValuesDaily Returns

Bone Biologics Corp  vs.  BioSig Technologies, Common

 Performance 
       Timeline  
Bone Biologics Corp 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Bone Biologics Corp are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak essential indicators, Bone Biologics reported solid returns over the last few months and may actually be approaching a breakup point.
BioSig Technologies, 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in BioSig Technologies, Common are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain technical and fundamental indicators, BioSig Technologies, displayed solid returns over the last few months and may actually be approaching a breakup point.

Bone Biologics and BioSig Technologies, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bone Biologics and BioSig Technologies,

The main advantage of trading using opposite Bone Biologics and BioSig Technologies, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bone Biologics position performs unexpectedly, BioSig Technologies, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioSig Technologies, will offset losses from the drop in BioSig Technologies,'s long position.
The idea behind Bone Biologics Corp and BioSig Technologies, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements